| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 05/11/2004 | US6733748 Chronic lymphocytic leukemia treatment |
| 05/07/2004 | CA2448481A1 A cell therapy method for the treatment of tumors |
| 05/06/2004 | WO2004037983A2 Caged ligands and uses thereof |
| 05/06/2004 | WO2004037287A2 Phototreatment device for use with coolants and topical substances |
| 05/06/2004 | WO2004037184A2 Methods for the treatment of skin disorders |
| 05/06/2004 | WO2004021982A3 Chemotherapy method using-rays |
| 05/06/2004 | WO2004009135A3 Conjugates of biocompatible polymers with nuclide activation therapy reagents |
| 05/06/2004 | WO2003079966A3 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 05/06/2004 | WO2003054176A3 Preparation of vaccines using photosensitizer and light |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040086581 Bio-energetic joint and arthritis pain formula |
| 05/06/2004 | US20040086572 Providing formulation comprising magnetic particles, having associated therapeutic agent, and using a magnetic field to move magnetic particles to desired location within eye |
| 05/06/2004 | US20040086492 Achieves a remarkable improvement in the effect of the treatment of a tumor such as cancer by administering activated lymphocytes over a specific period of time before or after the implementation of photodynamic therapy |
| 05/06/2004 | US20040086459 Efficient for back scattering ultrasound energy |
| 05/06/2004 | EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/06/2004 | EP1415669A1 Process for sterilization of protein containing biological compositions |
| 05/06/2004 | EP1414526A2 Antiangiogenic combination therapy for the treatment of cancer |
| 05/06/2004 | EP1414436A1 Radioprotective agents |
| 05/06/2004 | EP1414430A2 5-aminolevulinic acid and esters, in combination with another photosensitiser, as photosensitising agents in photochemotherapy, and their uses in treating wounds |
| 05/06/2004 | EP0959879B1 Photodynamic therapy for the treatment of osteoarthritis |
| 05/06/2004 | CA2501098A1 Phototreatment device for use with coolants and topical substances |
| 05/05/2004 | CN1493360A Preparation method of magnetic guiding anticancer medicine |
| 05/04/2004 | US6730699 Water soluble paclitaxel derivatives |
| 05/04/2004 | US6730028 Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
| 04/29/2004 | WO2004035590A2 Meso-substituted porphyrins |
| 04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
| 04/29/2004 | WO2004034889A2 Photodynamic therapy for ocular neovascularization |
| 04/29/2004 | WO2004034876A2 Magnetically guided particles for radiative therapies |
| 04/29/2004 | WO2001095899A8 Pharmaceutical compositions comprising cannabidiol derivatives |
| 04/29/2004 | US20040082936 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 04/29/2004 | US20040082764 Complex of antibodic and antibiotic with carrier |
| 04/29/2004 | US20040081956 Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/28/2004 | EP1413313A1 DIAGNOSIS AND TREATMENT OF INSULIN−DEPENDENT DIABETES MELLITUS AND INSULITIS |
| 04/28/2004 | EP1411927A1 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 04/28/2004 | EP0912174B1 Alteration of circadian rhythmicity with non-peptidal neurikinin-1 receptor antagonists |
| 04/28/2004 | EP0782455B1 Use of porphyrins in the treatment of multiple sclerosis |
| 04/28/2004 | EP0777498B1 Conjugates made of metal complexes and oligonucleotides |
| 04/27/2004 | US6726904 Polyurethane gel mass; lithotripsy and hyperthermia apparatus for therapy |
| 04/27/2004 | US6726895 Tumor radiotherapy |
| 04/22/2004 | WO2004032963A2 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 04/22/2004 | WO2004032876A2 Deguelin as a chemopreventive agent for lung cancer |
| 04/22/2004 | US20040077087 DNA damaging agents in combination with tyrosine kinase inhibitors |
| 04/21/2004 | EP1409516A2 Aromatic sulfenates for type i phototherapy |
| 04/21/2004 | EP1409482A2 Dye-sulfenates for dual phototherapy |
| 04/21/2004 | EP1409077A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 04/21/2004 | EP1409076A2 Method and apparatus for treating tumors using low strength electric fields |
| 04/21/2004 | EP1409015A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 04/21/2004 | EP1408955A1 Novel metallotexaphyrin derivatives |
| 04/15/2004 | WO2004030661A2 Therapeutic compositions comprising a boron-containing compound |
| 04/15/2004 | US20040073277 High fluence rate activation of photosensitizers for dermatological applications |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072139 Photodynamic treatment and uv-b-irradiation of a thrombocyte suspension |
| 04/15/2004 | US20040071671 Cell therapy method for the treatment of tumors |
| 04/15/2004 | US20040071664 Delivery of an agent |
| 04/15/2004 | US20040071632 Determining plaque location using human monoclonal antibody fragment cloned by phage display that binds specifically to oxidized forms of low density lipoproteins |
| 04/15/2004 | DE29624488U1 Inactivating parvovirus in blood and blood prods. with type C UV light - and device for the process, is simple and rapid and retains functionality of proteins |
| 04/14/2004 | EP1406914A2 Porphyrin derivatives for photodynamic therapy |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406591A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 04/14/2004 | EP1380295A9 Photosensitiser and method for production thereof |
| 04/14/2004 | EP1189906B1 Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
| 04/08/2004 | WO2004028338A2 A method to demonstrate the efficacy of pharmacological stress agent |
| 04/08/2004 | WO2004011631A3 Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus |
| 04/08/2004 | WO2004009136A3 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 04/08/2004 | WO2003101530A3 Solid hydrogel coupling for ultrasound imaging and therapy |
| 04/08/2004 | WO2003003806A3 Dye-azide compounds for dual phototherapy |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040067942 Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies |
| 04/08/2004 | US20040067892 Fullerene derivative and composition comprising the same |
| 04/08/2004 | US20040067198 Emissive multichromophoric systems |
| 04/07/2004 | EP1404678A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 04/07/2004 | EP1404379A2 Viral inactivation process using antioxidant |
| 04/07/2004 | EP1404334A1 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 04/07/2004 | EP1404319A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 04/06/2004 | US6716966 Therapeutic binding agents against MUC-1 antigen and methods for their use |
| 04/06/2004 | US6716412 Methods of ultrasound treatment using gas or gaseous precursor-filled compositions |
| 04/06/2004 | US6716410 Using humanized monoclonal antibody (mab) or fragment with variable chain with oxidation specific epitopes |
| 04/06/2004 | CA2225521C Laser assisted drug delivery apparatus |
| 04/06/2004 | CA2168575C Use of photodynamic therapy to treat prostatic tissue |
| 04/01/2004 | WO2004026345A1 Control of nitric oxide bioactivity by perfluorocarbons |
| 04/01/2004 | WO2004026340A1 Protein production |
| 04/01/2004 | WO2004026111A2 Flexible and/or elastic brachytherapy seed or strand |
| 04/01/2004 | WO2003091694A3 Method for assay of cognition and memory based on low frequency stimulation |
| 04/01/2004 | US20040062754 Photopheresis treatment of chronic HCV infections |
| 04/01/2004 | US20040062713 Dye; photosensitive stimulant; using eye |
| 04/01/2004 | CA2499398A1 Protein production |
| 03/31/2004 | EP1401875A1 Hyaluronic acid containing bioconjugates : targeted delivery of anti-cancer drugs to cancer cells |
| 03/31/2004 | EP1401506A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 03/31/2004 | EP1401479A2 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 03/31/2004 | CN1486191A Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 03/25/2004 | WO2004024877A2 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 03/25/2004 | WO2004024171A1 Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) |
| 03/25/2004 | WO2004024144A1 Method of treating skin disorders |
| 03/25/2004 | WO2004023899A1 Human and/or animal fiber-water including encapsulated additives having specific dietary and medical uses |
| 03/25/2004 | WO2004006954A3 Transdermal botulinum toxin compositions |
| 03/25/2004 | WO2002066044A3 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 03/25/2004 | US20040059313 Drug delivery by rupturing the microbubble, using ultrasound energy to activate the photosensitive drugs; releasing a thrombolytic agent into a blood vessel; using in therapy of targeting biological tumor, no cytotoxic on normal tissues |
| 03/25/2004 | US20040058857 Mixture of glucocorticoids and prostate specific antigen, or complex thereof; anticancer agents |
| 03/25/2004 | US20040058010 Drugs, bio-affecting and body treating compositions |